Publication | Closed Access

Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma

Tumor ImmunologyCancer ImmunosurveillanceMedicineMelanomaImmunologyMetastatic MelanomaImmune Checkpoint InhibitorActive Specific ImmunotherapyImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentSkin Cancer